Prakiraan pendapatan perusahaan Supernus Pharma (SUPN)

Logo perusahaan publik Supernus Pharmaceuticals, Inc. (SUPN)

The loss of patent protection for Trokendi XR triggered volatility, as evidenced by the projected sales revenue level, where the indicator value reaches 1.47. Professional management is effectively defending intellectual property rights, while high scalability through clinical trials ensures future profit growth for Supernus Pharmaceuticals (SUPN). This enables the company to successfully commercialize new products for the treatment of CNS disorders.

Supernus Pharmaceuticals - Pendapatan mangsa ngarep perusahaan SUPN (periode 04.07.2022 - 17.11.2026)

Rincian metrik keuangan lan pasar Supernus Pharma (SUPN)

Analisis komprehensif perusahaan:SUPN Supernus
Produk merek Supernus Pharmaceuticals, Inc.

To select high-quality assets, an investor must filter out marketing noise and identify real market demand by comparing the company with industry peers. This indicator measures hidden operating costs and actual sales interest, which is critical for Supernus Pharmaceuticals (SUPN) amid patent risks and dependence on CNS drugs, allowing for the prediction of revenue dynamics prior to earnings releases by assessing future sales volumes.

Pesaing langsung

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan CPRX (Catalyst Pharmaceuticals, Inc.)|Prakiraan pendapatan perusahaan Denali Therapeutics Inc|Volume dodolan sing dikarepake perusahaan Harmony Corp HRMY|Prakiraan volume dodolan BHVN|Volume dodolan mangsa ngarep perusahaan Amylyx Pharmaceuticals AMLX|Prakiraan volume dodolan TRVI (Trevi Corp)|Dodolan mangsa ngarep perusahaan Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Prakiraan volume dodolan|CeriBell Corp (CBLL) - Volume dodolan mangsa ngarep perusahaan|Prothena Corp (PRTA) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alector Inc. (ALEC)|Volume dodolan mangsa ngarep perusahaan ANNX|omeros.com (OMER) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VYGR (voyagertherapeutics.com)|Dodolan mangsa ngarep perusahaan Neumora Therapeutics (NMRA)|SCLX - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Prakiraan pendapatan perusahaan|CGTX - Dodolan mangsa ngarep perusahaan|IKT (inhibikase.com) - Prakiraan volume dodolan|cassavasciences.com (SAVA) - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan ASRT (Assertio Therapeutics)|Dodolan mangsa ngarep perusahaan Coya Therapeutics|Vistagen - Volume dodolan mangsa ngarep perusahaan|ovidrx.com (OVID) - Volume dodolan sing dikarepake perusahaan|Acumen Pharmaceuticals - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan cervomed.com|ATHE: Prakiraan volume dodolan|Clene Inc - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan PepGen|JUNS (Jupiter Neurosciences Inc) - Prakiraan volume pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan RLMD (Relmada Corp)|annovisbio.com - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan sing dikarepake perusahaan|KLTO - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MTVA|Volume dodolan mangsa ngarep perusahaan NRXS|Volume dodolan mangsa ngarep perusahaan Helius Medical (HSDT)|Prakiraan volume dodolan PASG|Neuphoria Therapeutics - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics